Expressing support for the designation of September 2017 as "Pulmonary Fibrosis Awareness Month".
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Sep 13, 2017)
Supports the designation of Pulmonary Fibrosis Awareness Month. (Pulmonary fibrosis is scarring of the lungs that causes breathing problems.)
Expresses continued support for: (1) more robust and accelerated research to develop more effective treatments for pulmonary fibrosis and to ultimately find a cure for the disease, (2) federal efforts to ease administrative burdens on those suffering from pulmonary fibrosis and their families and caregivers, and (3) swift and efficient federal evaluation and approval of new treatments for pulmonary fibrosis.
Recognizes the ongoing courage and contributions of individuals with pulmonary fibrosis who participate in clinical trials.
Commends the dedication of those working to improve the quality of life of individuals with pulmonary fibrosis and the families and caregivers of those individuals.What just happenedSep 15, 2017
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseSep 13, 2017
- Sep 15, 2017Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Sep 14, 2017IntroReferralB00100
Sponsor introductory remarks on measure. (CR H7413)
- Sep 13, 2017IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Sep 13, 2017IntroReferralIntro-H
Introduced in House
- Sep 13, 2017IntroReferral1000
Introduced in House